Ignorer et passer au contenu
Yuth LabsYuth Labs
Cerevel Therapeutics and Abbvie

Cerevel Therapeutics and Abbvie

Tavapadon (PF-06649751) is a dopamine receptor agonist targeting motor impairment in Parkinson’s disease. This small molecule aims to improve motor control by stimulating dopamine receptors in the brain.

Panier 0

Votre carte est actuellement vide.

Commencer à magasiner